6-5369076-A-T
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_006567.5(FARS2):c.506A>T(p.Asp169Val) variant causes a missense change. The variant allele was found at a frequency of 0.00025 in 1,613,932 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_006567.5 missense
Scores
Clinical Significance
Conservation
Publications
- metabolic diseaseInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- combined oxidative phosphorylation defect type 14Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- hereditary spastic paraplegia 77Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Leigh syndromeInheritance: AR Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FARS2 | NM_006567.5 | c.506A>T | p.Asp169Val | missense_variant | Exon 2 of 7 | ENST00000274680.9 | NP_006558.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FARS2 | ENST00000274680.9 | c.506A>T | p.Asp169Val | missense_variant | Exon 2 of 7 | 1 | NM_006567.5 | ENSP00000274680.4 | ||
| FARS2 | ENST00000324331.10 | c.506A>T | p.Asp169Val | missense_variant | Exon 2 of 7 | 1 | ENSP00000316335.5 | |||
| FARS2 | ENST00000648580.1 | n.506A>T | non_coding_transcript_exon_variant | Exon 2 of 9 | ENSP00000497889.1 |
Frequencies
GnomAD3 genomes AF: 0.00130 AC: 198AN: 152036Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000279 AC: 70AN: 251172 AF XY: 0.000177 show subpopulations
GnomAD4 exome AF: 0.000141 AC: 206AN: 1461778Hom.: 0 Cov.: 32 AF XY: 0.000106 AC XY: 77AN XY: 727196 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00130 AC: 198AN: 152154Hom.: 0 Cov.: 32 AF XY: 0.00132 AC XY: 98AN XY: 74406 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Combined oxidative phosphorylation defect type 14 Uncertain:2Benign:1
- -
- -
- -
not provided Benign:2
Reported as a variant of uncertain significance in siblings with juvenile idiopathic arthritis; these siblings were also homozygous for a variant in another gene that the authors classified as pathogenic (Rabinot et al., 2019); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30872671) -
- -
FARS2-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at